Total Debt (Carrying Amount)
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).
Debt item | Description | The company |
---|---|---|
Total debt (carrying amount) | Sum of the carrying values as of the balance sheet date of all debt plus capital lease obligations. | Edwards Lifesciences Corp. total debt increased from 2019 to 2020 and from 2020 to 2021. |
Total Debt (Fair Value)
Dec 31, 2021 | |
---|---|
Selected Financial Data (US$ in thousands) | |
Notes | 675,400) |
Credit Agreement | —) |
Total debt (fair value) | 675,400) |
Financial Ratio | |
Debt, fair value to carrying amount ratio | 1.13 |
Based on: 10-K (reporting date: 2021-12-31).
Weighted-average Interest Rate on Debt
Weighted-average interest rate under all debt obligations: 3.40%
Interest rate | Debt amount1 | Interest rate × Debt amount | Weighted-average interest rate2 |
---|---|---|---|
3.40% | 595,700) | 20,254) | |
Total | 595,700) | 20,254) | |
3.40% |
Based on: 10-K (reporting date: 2021-12-31).
1 US$ in thousands
2 Weighted-average interest rate = 100 × 20,254 ÷ 595,700 = 3.40%